Heron Therapeutics
HRTX
#7239
Rank
NZ$0.49 B
Marketcap
$3.27
Share price
3.59%
Change (1 day)
71.40%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.94

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.89. In 2022 the company made an earnings per share (EPS) of -$2.80 an increase over its 2021 EPS that were of -$3.64.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.94-30.49%
2022-$2.80-23.11%
2021-$3.64-10%
2020-$4.04-0%
2019-$4.041.21%
2018-$3.99-32.7%
2017-$5.93-19.34%
2016-$7.3554.76%
2015-$4.751.73%
2014-$4.67-16.23%
2013-$5.5891.67%
2012-$2.91-31.45%
2011-$4.24-27.06%
2010-$5.82-43.75%
2009-$10.34-57.33%
2008-$24.25-82.92%
2007-$141.9220.61%
2006-$117.67175.76%
2005-$42.67-21.43%
2004-$54.31100%
2003-$27.16-38.24%
2002-$43.97161.54%
2001-$16.81-106.46%
2000$260.072051.55%
1999$12.09839.73%
1998$1.29-105.48%
1997-$23.49-88.16%
1996-$198.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.10-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.23-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.63 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.54-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.67 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA